Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Schuster, S. J., Bishop, M. R., Tam, C., Waller, E. K., Borchmann, P., McGuirk, J., Jaeger, U., Jaglowski, S., Andreadis, C., Westin, J., Fleury, I., Bachanova, V., Foley, S. R., Ho, P. J., Mielke, S., Magenau, J. M., Holte, H., Anak, O., Pacaud, L., Awasthi, R., Tai, F., Salles, G. and Maziarz, R. T. (2017). GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - AN INTERIM ANALYSIS. Haematologica, 102. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Westin, J., Tam, C. S., Borchmann, P., Jaeger, U., McGuirk, J. P., Holte, H., Waller, E. K., Jaglowski, S., Bishop, M. R., Andreadis, C., Foley, S. R., Fleury, I, Ho, P. J., Mielke, S., Teshima, T., Schuster, S. J., Bachanova, V, Maziarz, R. T., Besien, K., V, Izutsu, K., Kersten, M. J., Wagner-Johnston, N. D., Kato, K., Corradini, P., Han, X., Tiwari, R., Eldjerou, L. K., Pacaud, L. B. and Salles, G. A. (2020). Correlative analyses of patient and clinical characteristics associated with efficacy in tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma patients in the JULIET trial. Oncol. Res. Treat., 43 (SUPPL 4). S. 58 - 59. BASEL: KARGER. ISSN 2296-5262

This list was generated on Fri Mar 29 15:51:22 2024 CET.